The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. MAIA Biotechnology Inc’s current trading price is -76.82% away from its 52-week high, while its distance from the 52-week low is -9.02%. The stock’s price range for this period has been between $1.33 and $5.22 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.98 million for the day, a number notably higher than the average daily volume of 0.29 million over the last three months.
At present, MAIA Biotechnology Inc (MAIA) has a stock price of $1.21. In the previous session, the stock saw a rise, peaking at $1.39 after an opening price of $1.36. The day’s lowest price was $1.05, and it closed at $1.40.
MAIA Biotechnology Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $5.22 on 02/13/23, while the lowest value for the same period was recorded at $1.33 on 11/17/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
MAIA Biotechnology Inc (MAIA) has experienced a quarterly decline of -36.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.65M and boasts a workforce of 18 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0211, with a change in price of -0.9100. Similarly, MAIA Biotechnology Inc recorded 208,348 in trading volume during the last 100 days, posting a change of -42.92%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MAIA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
MAIA Stock Stochastic Average
MAIA Biotechnology Inc’s raw stochastic average for the past 50 days is presently 8.84%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 11.51%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.47% and 14.57%, respectively.
MAIA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -65.53%.However, over the last six months, we can see a stronger performance of -50.00%. Over the last 30 days, the price of MAIA has leaped by -48.51%. And in the last five days, it has fallen by -39.20%.